Blocking androgen response could be key for halting tumor progression in prostate cancer
July 21st, 2010 Posted in hormone therapyResearchers at UT Southwestern Medical Center have found that blocking one of the enzymatic steps that allow the tumor to produce androgens could be the key in halting a tumor’s growth.
Previous studies showed that prostate cancer advances when tumors become resistant to hormone therapy, which is the standard treatment for patients, and begin producing their own androgens. Researchers suggest that this new step might one day provide a new avenue of therapy for patients with end-stage prostate cancer.
The findings will appear online in the August issue of Endocrinology.